• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLA360400
Medical Device Problem Code Malposition of Device (2616)
Health Effect - Clinical Code Occlusion (1984)
Date of Event 07/09/2020
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2019, this patient underwent endovascular treatment of bilateral iliac artery aneurysms using gore® excluder® aaa endoprostheses.On (b)(6) 2020, follow up ct revealed a dissection proximal to the celiac artery and a type 3 disconnect endoleak and type 1b endoleak on the right side.It was reported that during the original procedure on (b)(6) 2019, there was difficulty snaring the guidewire, which might have led to wire trauma in the aorta, causing or contributing to a dissection.This was reported to fda on mfr report # 3007284313-2019-00143.On (b)(6) 2020, the physician treated the dissection with a 36mm aortic extender component that covered the fenestration.However, during deployment of the aortic extender, the device was inadvertently deployed over the soft portion of the guidewire, which caused the delivery catheter to rotate and move distally during deployment, and the celiac artery was partially covered.The physician then cannulated the celiac artery and deployed an 8x20 mm gore® viabahn® vbx device and extended proximally in the aorta with another 36 mm aortic extender component.The type 3 endoleak between the ceb endoprosthesis and the plc231400 in the right limb was treated with a plc271400 contralateral leg component.The type 1b was treated with an 8x59 gore® viabahn® vbx successfully.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER CONFORMABLE AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10373802
Report Number3007284313-2020-01024
Device Sequence Number2888796
Product Code MIH
UDI-Device Identifier00733132618439
UDI-Public00733132618439
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/03/2023
Device Model NumberPLA360400
Device Catalogue NumberPLA360400
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/09/2020
Initial Report FDA Received Date08/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
-
-